Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the COSYCONET cohort.

Trudzinski FC, Kahnert K, Vogelmeier CF, Alter P, Seiler F, Fähndrich S, Watz H, Welte T, Speer T, Zewinger S, Biertz F, Kauczor HU, Jörres RA, Bals R; COSYCONET consortium.

Respir Med. 2019 Jul - Aug;154:18-26. doi: 10.1016/j.rmed.2019.06.007. Epub 2019 Jun 11.

PMID:
31203096
2.

A small molecule neutrophil elastase inhibitor, KRP-109, inhibits cystic fibrosis mucin degradation.

Chillappagari S, Müller C, Mahavadi P, Guenther A, Nährlich L, Rosenblum J, Rubin BK, Henke MO.

J Cyst Fibros. 2016 May;15(3):325-31. doi: 10.1016/j.jcf.2015.10.008. Epub 2015 Oct 30.

3.

Altered protease and antiprotease balance during a COPD exacerbation contributes to mucus obstruction.

Chillappagari S, Preuss J, Licht S, Müller C, Mahavadi P, Sarode G, Vogelmeier C, Guenther A, Nahrlich L, Rubin BK, Henke MO.

Respir Res. 2015 Jul 15;16:85. doi: 10.1186/s12931-015-0247-x.

4.

Impaired TLR4 and HIF expression in cystic fibrosis bronchial epithelial cells downregulates hemeoxygenase-1 and alters iron homeostasis in vitro.

Chillappagari S, Venkatesan S, Garapati V, Mahavadi P, Munder A, Seubert A, Sarode G, Guenther A, Schmeck BT, Tümmler B, Henke MO.

Am J Physiol Lung Cell Mol Physiol. 2014 Nov 15;307(10):L791-9. doi: 10.1152/ajplung.00167.2014. Epub 2014 Sep 19.

5.

Secretory hyperresponsiveness and pulmonary mucus hypersecretion.

Rubin BK, Priftis KN, Schmidt HJ, Henke MO.

Chest. 2014 Aug;146(2):496-507. doi: 10.1378/chest.13-2609. Review.

PMID:
25091755
6.

Clarithromycin therapy for patients with cystic fibrosis: a randomized controlled trial.

Robinson P, Schechter MS, Sly PD, Winfield K, Smith J, Brennan S, Shinkai M, Henke MO, Rubin BK.

Pediatr Pulmonol. 2012 Jun;47(6):551-7. doi: 10.1002/ppul.21613. Epub 2012 Jan 20.

PMID:
22266895
7.

Reduced surface toll-like receptor-4 expression and absent interferon-γ-inducible protein-10 induction in cystic fibrosis airway cells.

John G, Chillappagari S, Rubin BK, Gruenert DC, Henke MO.

Exp Lung Res. 2011 Aug;37(6):319-26. doi: 10.3109/01902148.2011.569968. Epub 2011 Jun 7.

PMID:
21649525
8.

Serine proteases degrade airway mucins in cystic fibrosis.

Henke MO, John G, Rheineck C, Chillappagari S, Naehrlich L, Rubin BK.

Infect Immun. 2011 Aug;79(8):3438-44. doi: 10.1128/IAI.01252-10. Epub 2011 Jun 6.

9.

High diagnostic yield from transbronchial biopsy of solitary pulmonary nodules using low-dose CT-guidance.

Hautmann H, Henke MO, Bitterling H.

Respirology. 2010 May;15(4):677-82. doi: 10.1111/j.1440-1843.2010.01741.x. Epub 2010 Mar 29.

PMID:
20409025
10.

TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells.

John G, Yildirim AO, Rubin BK, Gruenert DC, Henke MO.

Am J Respir Cell Mol Biol. 2010 Apr;42(4):424-31. doi: 10.1165/rcmb.2008-0408OC. Epub 2009 Jun 5.

11.

Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action.

Shinkai M, Henke MO, Rubin BK.

Pharmacol Ther. 2008 Mar;117(3):393-405. doi: 10.1016/j.pharmthera.2007.11.001. Epub 2007 Dec 15. Review.

PMID:
18289694
12.
13.

Mucolytics in cystic fibrosis.

Henke MO, Ratjen F.

Paediatr Respir Rev. 2007 Mar;8(1):24-9. Epub 2007 Mar 21. Review.

PMID:
17419975
14.

MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation.

Henke MO, John G, Germann M, Lindemann H, Rubin BK.

Am J Respir Crit Care Med. 2007 Apr 15;175(8):816-21. Epub 2007 Jan 25.

PMID:
17255563
15.

The role of airway secretions in COPD--clinical applications.

Henke MO, Shah SA, Rubin BK.

COPD. 2005 Sep;2(3):377-90. Review.

PMID:
17147002
16.

Up-regulation of S100A8 and S100A9 protein in bronchial epithelial cells by lipopolysaccharide.

Henke MO, Renner A, Rubin BK, Gyves JI, Lorenz E, Koo JS.

Exp Lung Res. 2006 Sep;32(8):331-47.

PMID:
17090475
17.

Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis.

Bush A, Payne D, Pike S, Jenkins G, Henke MO, Rubin BK.

Chest. 2006 Jan;129(1):118-23.

PMID:
16424421
18.

MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.

Henke MO, Renner A, Huber RM, Seeds MC, Rubin BK.

Am J Respir Cell Mol Biol. 2004 Jul;31(1):86-91. Epub 2004 Feb 26.

PMID:
14988081
19.

Immunomodulatory activity and effectiveness of macrolides in chronic airway disease.

Rubin BK, Henke MO.

Chest. 2004 Feb;125(2 Suppl):70S-78S. Review.

PMID:
14872003
20.

Human deep tissue infection with an entomopathogenic Beauveria species.

Henke MO, De Hoog GS, Gross U, Zimmermann G, Kraemer D, Weig M.

J Clin Microbiol. 2002 Jul;40(7):2698-702.

Supplemental Content

Loading ...
Support Center